CEN Biotech, Inc.
CENBF
$0.0001
$0.000.00%
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | -420.20K | -348.30K | -258.90K | -2.07M | -718.90K |
| Total Depreciation and Amortization | 200.90K | 25.20K | 93.90K | 107.80K | 141.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | 28.40K | 8.80K |
| Total Other Non-Cash Items | 146.00K | 5.00K | 0.00 | 1.80M | 390.60K |
| Change in Net Operating Assets | -16.80K | -45.00K | 107.00K | 53.90K | 199.50K |
| Cash from Operations | -90.10K | -363.10K | -58.00K | -79.50K | 21.40K |
| Capital Expenditure | -- | -- | -- | -4.20K | -19.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00 | 259.50K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -52.60K | -53.80K |
| Cash from Investing | -- | -- | -- | -56.80K | 186.70K |
| Total Debt Issued | 82.80K | 70.00K | -- | 110.00K | 4.40K |
| Total Debt Repaid | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Common Stock | -- | 406.30K | -- | -- | -- |
| Repurchase of Common Stock | -92.60K | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -9.80K | 476.30K | -- | 110.00K | 4.40K |
| Foreign Exchange rate Adjustments | -- | -- | -- | 5.70K | -9.60K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -100.00K | 113.20K | -58.00K | -20.60K | 203.00K |
